DSGN Stock, Design Therapeutics Inc. Information
Stock Information
Get DSGN Alerts
News, Short Squeeze, Breakout and More Instantly...
About Design Therapeutics Inc.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.